全文获取类型
收费全文 | 28164篇 |
免费 | 1392篇 |
国内免费 | 161篇 |
专业分类
耳鼻咽喉 | 367篇 |
儿科学 | 450篇 |
妇产科学 | 495篇 |
基础医学 | 3525篇 |
口腔科学 | 737篇 |
临床医学 | 2062篇 |
内科学 | 7765篇 |
皮肤病学 | 311篇 |
神经病学 | 2052篇 |
特种医学 | 930篇 |
外科学 | 4779篇 |
综合类 | 142篇 |
一般理论 | 1篇 |
预防医学 | 807篇 |
眼科学 | 461篇 |
药学 | 1930篇 |
中国医学 | 49篇 |
肿瘤学 | 2854篇 |
出版年
2023年 | 167篇 |
2022年 | 366篇 |
2021年 | 600篇 |
2020年 | 300篇 |
2019年 | 386篇 |
2018年 | 550篇 |
2017年 | 433篇 |
2016年 | 518篇 |
2015年 | 520篇 |
2014年 | 697篇 |
2013年 | 863篇 |
2012年 | 1334篇 |
2011年 | 1488篇 |
2010年 | 791篇 |
2009年 | 702篇 |
2008年 | 1334篇 |
2007年 | 1395篇 |
2006年 | 1332篇 |
2005年 | 1252篇 |
2004年 | 1245篇 |
2003年 | 1198篇 |
2002年 | 1242篇 |
2001年 | 934篇 |
2000年 | 957篇 |
1999年 | 827篇 |
1998年 | 324篇 |
1997年 | 238篇 |
1996年 | 229篇 |
1995年 | 195篇 |
1994年 | 180篇 |
1993年 | 151篇 |
1992年 | 604篇 |
1991年 | 635篇 |
1990年 | 541篇 |
1989年 | 543篇 |
1988年 | 532篇 |
1987年 | 504篇 |
1986年 | 433篇 |
1985年 | 432篇 |
1984年 | 317篇 |
1983年 | 243篇 |
1979年 | 232篇 |
1978年 | 136篇 |
1977年 | 138篇 |
1974年 | 128篇 |
1973年 | 119篇 |
1972年 | 137篇 |
1971年 | 127篇 |
1969年 | 137篇 |
1967年 | 128篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Hiroto Kinoshita Hitomi Nishioka Aya Ikeda Kyoko Ikoma Yoichi Sameshima Hidehisa Ohi Mizuki Tatsuno Junka Kouyama Chiaki Kawamoto Tomohiro Mitsui Yuko Tamura Yu Hashimoto Masashi Nishio Tsuyoshi Ogashiwa Yusuke Saigusa Shin Maeda Hideaki Kimura Reiko Kunisaki Kazuhiko Koike 《Journal of gastroenterology and hepatology》2019,34(11):1929-1939
6.
7.
Hideki Kawaguchi Kazuko Masuo Tomohiro Katsuya Ken Sugimoto Hiromi Rakugi Toshio Ogihara Michael L Tuck 《Hypertension research》2006,29(12):951-959
High blood pressure (BP) is a major determinant of cardiovascular events in obesity. The beta2- and beta3-adrenoceptor polymorphisms are associated with obesity and hypertension. In the present study, we examine the relationships of beta2- and beta3-adrenoceptor polymorphisms with further weight gain-induced BP elevation in obese subjects. Changes in BP, body weight, total body fat-mass, waist-to-hip ratio, plasma norepinephrine (NE) and leptin levels, and beta2(Arg16Gly)- and beta3(Trp64Arg)-adrenoceptor polymorphisms were measured periodically over a 5-year period in 55 entry obese (body mass index [BMI]> or =25.0 kg/m(2)) normotensive (BP<140/90 mmHg) men. BP elevation and weight gain were defined as > or =10% increases from entry levels over 5 years in mean BP or BMI. Obese subjects with weight gain, BP elevation or weight gain-induced BP elevation had higher frequencies of the Gly16 allele of Arg16GIy and Arg64 allele of Trp64Arg. Subjects carrying the Gly16 or Arg64 alleles had significantly greater total fat-mass and waist-to-hip ratio at entry and over a 5-year period compared to the subjects who did not carry these polymorphisms. Subjects carrying the Gly16 allele had similar levels of plasma NE, higher levels of plasma leptin and a lower slope of the regression lines between plasma leptin and NE levels. Those carrying the Arg64 allele had higher plasma NE levels at entry and over a 5-year period compared to the subjects without the Arg64 allele, but plasma leptin levels and slopes were similar. The findings demonstrate that the Arg64 allele of the beta3-adrenoceptor polymorphisms relates to weight gain-induced BP elevation accompanying high plasma NE (heightened sympathetic activity) in obese men. The Gly16 allele of the beta2-adrenoceptor polymorphisms links to weight gain-induced BP elevation associated with leptin resistance. beta2- and beta3-adrenoceptor polymorphisms could predict the future BP elevation and further weight gain-induced BP elevation in originally obese subjects. 相似文献
8.
Koji Saito Takashi Saito Sumio Kawada 《Nihon Shokakibyo Gakkai zasshi》2006,103(10):1176, 1179-1176, 1180
9.
Masahiro Yamauchi Hiroko Kusano Etsuko Saito Takeshi Iwata Masashi Nakakura Yasuki Kato Takaaki Uochi Shiro Akinaga Noboru Aoki 《Journal of controlled release》2006,114(2):268-275
Previously, we demonstrated that wrapping dextran fluorescein anionic/cationic lipid complexes with neutral lipids produced a stable formulation that markedly increased the duration of the compound in plasma after intravenous administration to rats. The improved drug-delivery properties of the wrapped liposomes (WL) relative to other formulations suggested that this technology could offer important advantages for the administration of other polyanionic drugs, including antisense oligodeoxynucleotides (ODN). In the present study, we investigated the value of WL for formulating fluorescence-labeled phosphorothioated ODN (F-ODN). WL encapsulating F-ODN/cationic lipid complexes were prepared efficiently using similar methodology to that used in our earlier study. Studies confirmed that these WL were stable in vitro. Following intravenous administration to mice, free F-ODN and naked F-ODN/cationic lipid complexes were rapidly eliminated whereas administration of the WL resulted in high blood concentrations of drug that were maintained for several hours. Additional studies were conducted in mice that were inoculated with tumor cells (Caki-1 xenograft model, human kidney); in these experiments, intravenous administration of WL delivered 13 times more F-ODN to the tumor site than achieved after injection of free F-ODN. 相似文献